This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dunn Sievers, T. Articles by Blanding, P. J. Search for Related Content PubMed PubMed Citation Articles by Dunn Sievers, T. Articles by Blanding, P. J. Social Bookmarking                         What's this?

Variation in Administration of Cyclophosphamide and Mesna in the Treatment of Childhood Malignancies

Mary Anne Lagan, BSN, RN

Sylvia B. Bartel, RPh, MS

Christina Rasco, MS, RN, PNP

Peter J. Blanding, RPh, MS

The objective of this study was to describe the variation in preparation and administration of cyclophosphamide, mesna, and hydration for the treat ment of childhood malignancies within clinical trial protocol documents. All cyclophosphamide-containing cooperative group (Pediatric Oncology Group) protocols that were open at Dana-Farber Cancer Institute in April 1998 were evaluated. Among the 14 active protocols, there were 23 unique cyclophosphamide regimens. Marked variation existed in infusion rate, fluid type, and volume used for admixing cyclophosphamide and mesna, as defined in the "Treatment" section of the protocols that we evaluated. Further variation was found in the type, amount, and rate of infusion of prehydration and posthydration fluid. Internal inconsistency existed within the protocols pertaining to the administration methods described in the "Agent Information," "Treatment," and "Consent" sec tions of the written documents. Clinical trial protocol documents serve as reference material for health care providers who prescribe, dispense, and administer protocol chemotherapy. Misinterpretation of protocol docu ments and clinician orders are contributing factors in serious and deadly medication errors. Internal inconsistency within protocol documents and variation in drug administration across protocols is a potential source of error. We recommend improved accuracy, clarity, and internal consistency of protocol documents to improve patient safety and compliance with protocol specifications. In addition, the use of standard concentrations, volumes, and methods of administration of chemotherapeutic agents and accompanying fluids is recommended.

Journal of Pediatric Oncology Nursing, Vol. 18, No. 1, 37-45 (2001)
DOI: 10.1177/104345420101800105


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Menard, C. Bourguignon, J. Schlatter, and N. Vermerie Stability of Cyclophosphamide and Mesna Admixtures in Polyethylene Infusion Bags Ann. Pharmacother., December 1, 2003; 37(12): 1789 - 1792. [Abstract] [Full Text] [PDF]

				R. B. Womer, E. Tracy, W. Soo-Hoo, B. Bickert, S. DiTaranto, and J. H. Barnsteiner Multidisciplinary Systems Approach to Chemotherapy Safety: Rebuilding Processes and Holding the Gains J. Clin. Oncol., December 15, 2002; 20(24): 4705 - 4712. [Abstract] [Full Text] [PDF]